Dois-je éviter lithium carbonate pendant la grossesse ? | VeriMom
ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).
ECHA regulatory hazard statements
- •H360
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- lithium carbonate est-il sûr pendant la grossesse ?
- ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).
- lithium carbonate est-il sûr pendant l'allaitement ?
- ECHA’s adopted opinion includes H362 (dangerous for or via breast‑feeding), and clinical data on medicinal lithium show lithium is excreted in human milk and can produce neonatal toxicity—supporting a high hazard (h=3) and demonstrated mechanism (m=2). For topical cosmetic applications, dermal absorption is considered very poor so direct exposure via cosmetic use is expected to be negligible, though systemic exposure from medicinal use is well documented. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; product/labeling and clinical literature on lithium in breast milk).
- lithium carbonate est-il sûr pour la peau de bébé ?
- Hazard and mechanism are driven by harmonised CLH (Repr.1A H360FD) and clinical/animal evidence of placental transfer and milk excretion—these apply to infants (h=3, m=2). Exposure (e) for topical cosmetic use is judged low/negligible in adults (ECHA: dermal absorption very poor), but infant skin has higher uptake potential so exposure is increased by +1 to e=1 as a precaution for 0–3‑year skin when the ingredient is present in topical products. There is no evidence that cosmetic-grade topical use produces systemic infant exposure, but the harmonised classification leads to conservative scoring for infant contexts. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed clinical/animal studies).
- Comment VeriMom évalue-t-il lithium carbonate ?
- VeriMom évalue lithium carbonate à 27/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à lithium carbonate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à lithium carbonate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.